|
Positie houder
|
Naam van de emittent
|
ISIN
|
Netto Shortpositie
|
Positiedatum
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Alfen N.V.
|
NL0012817175
|
0.96
|
12 Sep 2024
|
|
Cubist Systematic Strategies, LLC
|
Alfen N.V.
|
NL0012817175
|
0.43
|
12 Sep 2024
|
|
Capital Fund Management S.A.
|
AMG Critical Materials N.V.
|
NL0000888691
|
0.74
|
12 Sep 2024
|
|
Citadel Advisors LLC
|
Alfen N.V.
|
NL0012817175
|
1.5
|
12 Sep 2024
|
|
Citadel Securities (Europe) Limited
|
Vivoryon Therapeutics N.V.
|
NL00150002Q7
|
0.51
|
12 Sep 2024
|
|
SIH Partners LLLP
|
ARCADIS N.V.
|
NL0006237562
|
1.13
|
12 Sep 2024
|
|
Qube Research & Technologies Ltd.
|
Alfen N.V.
|
NL0012817175
|
1.95
|
12 Sep 2024
|
|
Voleon Capital Management LP
|
Vivoryon Therapeutics N.V.
|
NL00150002Q7
|
0.57
|
12 Sep 2024
|
|
TFG Asset Management UK LLP
|
Fugro N.V.
|
NL0000352565
|
0.57
|
11 Sep 2024
|
|
Voleon Capital Management LP
|
Vivoryon Therapeutics N.V.
|
NL00150002Q7
|
0.77
|
11 Sep 2024
|
|
Qube Research & Technologies Ltd.
|
PostNL N.V.
|
NL0009739416
|
1.0
|
11 Sep 2024
|
|
Millennium International Management LP
|
Alfen N.V.
|
NL0012817175
|
2.07
|
11 Sep 2024
|
|
Qube Research & Technologies Ltd.
|
Alfen N.V.
|
NL0012817175
|
2.12
|
11 Sep 2024
|
|
Capital Fund Management S.A.
|
AMG Critical Materials N.V.
|
NL0000888691
|
0.89
|
11 Sep 2024
|
|
Citadel Advisors LLC
|
Alfen N.V.
|
NL0012817175
|
1.47
|
11 Sep 2024
|
|
Marshall Wace LLP
|
AMG Critical Materials N.V.
|
NL0000888691
|
1.25
|
11 Sep 2024
|
|
Marshall Wace LLP
|
PostNL N.V.
|
NL0009739416
|
0.88
|
11 Sep 2024
|
|
Systematica Investments Limited
|
Alfen N.V.
|
NL0012817175
|
0.5
|
11 Sep 2024
|
|
BlackRock Investment Management (UK) Limited
|
Basic-Fit N.V.
|
NL0011872650
|
1.26
|
11 Sep 2024
|
|
AQR Capital Management, LLC
|
ASR Nederland N.V.
|
NL0011872643
|
0.7
|
11 Sep 2024
|
|
Qube Research & Technologies Ltd.
|
Alfen N.V.
|
NL0012817175
|
2.2
|
10 Sep 2024
|
|
Qube Research & Technologies Ltd.
|
TomTom N.V.
|
NL0013332471
|
0.51
|
10 Sep 2024
|
|
SIH Partners LLLP
|
Alfen N.V.
|
NL0012817175
|
0.61
|
10 Sep 2024
|
|
Millennium Capital Partners LLP
|
Alfen N.V.
|
NL0012817175
|
2.01
|
10 Sep 2024
|
|
Citadel Securities (Europe) Limited
|
Vivoryon Therapeutics N.V.
|
NL00150002Q7
|
0.7
|
10 Sep 2024
|
|
Cubist Systematic Strategies, LLC
|
Alfen N.V.
|
NL0012817175
|
0.58
|
10 Sep 2024
|
|
Citadel Advisors LLC
|
Alfen N.V.
|
NL0012817175
|
1.52
|
10 Sep 2024
|
|
BlackRock Investment Management (UK) Limited
|
Basic-Fit N.V.
|
NL0011872650
|
1.42
|
10 Sep 2024
|
|
Acadian Asset Management LLC.
|
AMG Critical Materials N.V.
|
NL0000888691
|
0.52
|
10 Sep 2024
|
|
SIH Partners LLLP
|
ARCADIS N.V.
|
NL0006237562
|
0.99
|
09 Sep 2024
|
|
Qube Research & Technologies Ltd.
|
Flow Traders Ltd.
|
BMG3602E1084
|
1.89
|
09 Sep 2024
|
|
Qube Research & Technologies Ltd.
|
PostNL N.V.
|
NL0009739416
|
0.99
|
09 Sep 2024
|
|
GSA Capital Partners LLP
|
PostNL N.V.
|
NL0009739416
|
0.49
|
09 Sep 2024
|
|
Marshall Wace LLP
|
Akzo Nobel N.V.
|
NL0013267909
|
0.5
|
09 Sep 2024
|
|
Millennium International Management LP
|
Pharming Group N.V.
|
NL0010391025
|
1.72
|
09 Sep 2024
|
|
Millennium International Management LP
|
Alfen N.V.
|
NL0012817175
|
1.93
|
09 Sep 2024
|
|
Cubist Systematic Strategies, LLC
|
Alfen N.V.
|
NL0012817175
|
0.65
|
09 Sep 2024
|
|
Qube Research & Technologies Ltd.
|
Alfen N.V.
|
NL0012817175
|
2.18
|
09 Sep 2024
|
|
Capital Fund Management S.A.
|
AMG Critical Materials N.V.
|
NL0000888691
|
0.92
|
09 Sep 2024
|
|
Marshall Wace LLP
|
ArcelorMittal S.A.
|
LU1598757687
|
0.78
|
06 Sep 2024
|
